| Type of Restructuring [Domain] | |
Employee-Related Items and Benefits [Member] | Contract Terminations and Other [Member] | Asset Impairments [Member] |
2006 | Restructuring Reserve [Line Items] | Restructuring Reserve, Period Expense | | Parmaceuticals Business Actions [Member] | 97,000,000 | 8,000,000 | 61,000,000 | 166,000,000 |
Overhead Reduction Actions [Member] | 112,000,000 | | | 112,000,000 |
Business-Specific Actions [Member] | 34,000,000 | 8,000,000 | 83,000,000 | 125,000,000 |
Restructuring Expense Items [Domain] | 243,000,000 | 16,000,000 | 144,000,000 | 403,000,000 |
Restructuring Reserve, Settled without Cash | | Parmaceuticals Business Actions [Member] | 19,000,000 | | 61,000,000 | 80,000,000 |
Overhead Reduction Actions [Member] | 12,000,000 | | | 12,000,000 |
Business-Specific Actions [Member] | 4,000,000 | | 83,000,000 | 87,000,000 |
Restructuring Expense Items [Domain] | 35,000,000 | | 144,000,000 | 179,000,000 |
Restructuring Reserve, Settled with Cash | | Parmaceuticals Business Actions [Member] | | 2,000,000 | | 2,000,000 |
Restructuring Expense Items [Domain] | | 2,000,000 | | 2,000,000 |
Restructuring Reserve, Accrual Adjustment | | Parmaceuticals Business Actions [Member] | 78,000,000 | 6,000,000 | | 84,000,000 |
Overhead Reduction Actions [Member] | 100,000,000 | | | 100,000,000 |
Business-Specific Actions [Member] | 30,000,000 | 8,000,000 | | 38,000,000 |
Restructuring Expense Items [Domain] | 208,000,000 | 14,000,000 | | 222,000,000 |
2007 | Restructuring Reserve [Line Items] | Restructuring Reserve, Period Expense | | Parmaceuticals Business Actions [Member] | 12,000,000 | 4,000,000 | | 16,000,000 |
Overhead Reduction Actions [Member] | 2,000,000 | | | 2,000,000 |
Business-Specific Actions [Member] | 13,000,000 | 4,000,000 | 35,000,000 | 52,000,000 |
Restructuring Expense Items [Domain] | 3,000,000 | | 35,000,000 | 38,000,000 |
Restructuring Reserve, Settled without Cash | | Parmaceuticals Business Actions [Member] | 21,000,000 | 4,000,000 | | 17,000,000 |
Overhead Reduction Actions [Member] | 5,000,000 | | | 5,000,000 |
Business-Specific Actions [Member] | 12,000,000 | 4,000,000 | 35,000,000 | 51,000,000 |
Restructuring Expense Items [Domain] | | | 35,000,000 | 73,000,000 |
Restructuring Reserve, Settled with Cash | | Parmaceuticals Business Actions [Member] | 40,000,000 | 6,000,000 | | 46,000,000 |
Overhead Reduction Actions [Member] | 87,000,000 | | | 87,000,000 |
Business-Specific Actions [Member] | 26,000,000 | 8,000,000 | | 34,000,000 |
Restructuring Expense Items [Domain] | 153,000,000 | 14,000,000 | | 167,000,000 |
Restructuring Reserve, Accrual Adjustment | | Parmaceuticals Business Actions [Member] | 5,000,000 | | | 5,000,000 |
Overhead Reduction Actions [Member] | 10,000,000 | | | 10,000,000 |
Business-Specific Actions [Member] | 5,000,000 | | | 5,000,000 |
Restructuring Expense Items [Domain] | 20,000,000 | | | 20,000,000 |